Helius Medical Technologies, Inc. (NASDAQ:HSDT – Get Free Report) was the recipient of a large decline in short interest in the month of November. As of November 30th, there was short interest totalling 89,800 shares, a decline of 5.5% from the November 15th total of 95,000 shares. Based on an average daily volume of 361,500 shares, the short-interest ratio is presently 0.2 days.
Analyst Ratings Changes
Separately, Maxim Group reissued a “hold” rating on shares of Helius Medical Technologies in a report on Wednesday, October 16th.
View Our Latest Stock Report on HSDT
Institutional Trading of Helius Medical Technologies
Helius Medical Technologies Stock Down 2.1 %
NASDAQ:HSDT opened at $0.48 on Tuesday. Helius Medical Technologies has a 52 week low of $0.37 and a 52 week high of $9.50. The stock’s 50-day moving average price is $0.52 and its 200-day moving average price is $0.74. The stock has a market capitalization of $1.79 million, a PE ratio of -0.08 and a beta of 1.68.
Helius Medical Technologies Company Profile
Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.
See Also
- Five stocks we like better than Helius Medical Technologies
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Semtech Stock Climbs as AI Boom Drives Turnaround Success
- How Investors Can Find the Best Cheap Dividend Stocks
- 3 Companies Leading the Way With Aggressive Stock Buybacks
- What Makes a Stock a Good Dividend Stock?
- Is It Time to Buy Nuclear Energy Stocks After the Latest Dip?
Receive News & Ratings for Helius Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helius Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.